"10.1371_journal.pone.0096663","plos one","2014-05-07T00:00:00Z","Francesco Pallotti; Giorgio Binelli; Raffaella Fabbri; Maria L Valentino; Rossella Vicenti; Maria Macciocca; Sabina Cevoli; Agostino Baruzzi; Salvatore DiMauro; Valerio Carelli","Department of Neurology, Columbia University, New York City, New York, United States of America; Dipartimento di Scienze Chirurgiche e Morfologiche, University of Insubria, Varese, Italy; Dipartimento di Scienze Teoriche e Applicate, University of Insubria, Varese, Italy; Unità Operativa di Ginecologia e Fisiopatologia della Riproduzione Umana, Ospedale S.Orsola-Malpighi, University of Bologna, Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), University of Bologna, Bologna, Italy; IRCCS Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy; Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), University of Bologna, Bologna, Italy","Conceived and designed the experiments: FP AB SDM VC. Performed the experiments: FP GB RF MLV RV MM. Analyzed the data: FP GB RF MLV RV MM SDM VC. Contributed reagents/materials/analysis tools: RF MLV SC. Wrote the paper: FP GB RF MLV VC.","VC is currently receiving funding for the following clinical trials: clinical trial with EPI-743 (α-tocotrienol quinone) in Lebers hereditary optic neuropathy, Edison Pharmaceuticals, USA, and clinical trial with l-acetyl carnitine in Lebers hereditary optic neuropathy, Sigma-tau, Italy. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","05","Francesco Pallotti","FP",10,TRUE,4,6,8,5,TRUE,TRUE,FALSE,0,NA,FALSE
